The Heart Attack Diagnostic Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Heart Attack Diagnostic Market:
https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report
According to The Business Research Company’s Heart Attack Diagnostic Global Market Report 2024, The heart attack diagnostic market size has grown strongly in recent years. It will grow from $10.21 billion in 2023 to $11.07 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to development of cardiac biomarkers,introduction of ecg and imaging, standardization of diagnostic protocols, awareness and education initiatives, improvements in troponin testing.
The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $15.26 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to patient empowerment and engagement, data analytics and precision medicine, preventive healthcare initiatives, healthcare infrastructure development, personalized diagnostic approaches.. Major trends in the forecast period include point-of-care testing, high-sensitivity troponin tests, non-invasive imaging techniques, personalized medicine, remote monitoring devices.
The rising prevalence of cardiac disorders is propelling the growth of the heart attack diagnostics market. Cardiac disorders (CVD) are a group of disorders of the heart and blood vessels affecting the heart. Unhealthy eating, inactivity, usage of tobacco products, and abusing alcohol are the main factors for heart disease and stroke. Heart attack diagnosis helps in analyzing the causes and severity of heart attack, stroke, and heart failure. For instance, a World Health Organization (WHO) study from 2021 estimated that 17.9 million people worldwide died from cardiovascular diseases (CVDs), accounting for 32% of all deaths and 85% of these deaths were due to heart attacks and strokes. This shows the number of people getting cardiovascular disease (CVD) is steadily rising, including one-third of all deaths globally. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the heart attack diagnostics market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8498&type=smp
The heart attack diagnostic market covered in this report is segmented –
1) By Test Type: Electrocardiogram (ECG/EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
The development of novel diagnostic techniques for heart disease is a key trend in the heart diagnostic market. Major players are developing novel technologies such as artificial intelligence for heart disease diagnosis. Artificial intelligence (AI) is the emulation of human intellect in devices that have been designed to behave and think like humans. AI is utilized to improve the skills of diagnostic radiography, diagnose heart problems, and treat strokes more quickly. For instance, in February 2022, Physician-scientists at the Smidt Heart Institute at Cedars-Sinai, a nonprofit academic healthcare organization, developed an AI-based method to identify hard-to-diagnose cardiac conditions. The AI program can identify illness patterns that are invisible to the human eye and utilize these patterns to forecast the correct diagnosis. Hypertrophic cardiomyopathy and cardiac amyloidosis disorders, which can both be fatal, are efficiently recognized and distinguished by artificial intelligence (AI) technology.
The heart attack diagnostic market report table of contents includes:
1. Executive Summary
2. Heart Attack Diagnostic Market Characteristics
3. Heart Attack Diagnostic Market Trends And Strategies
4. Heart Attack Diagnostic Market – Macro Economic Scenario
5. Global Heart Attack Diagnostic Market Size and Growth
.
.
.
26. South America Heart Attack Diagnostic Market
27. Brazil Heart Attack Diagnostic Market
28. Middle East Heart Attack Diagnostic Market
29. Africa Heart Attack Diagnostic Market
30. Heart Attack Diagnostic Market Competitive Landscape And Company Profiles
Top Major Players:
- Abbott Laboratories
- F. Hoffmann-La Roche AG
- General Electric Co
- Hitachi Ltd
- Koninklijke Philips NV
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
